CN110179925A - A kind of Chinese medicine composition and preparation method thereof for treating respiratory disease - Google Patents
A kind of Chinese medicine composition and preparation method thereof for treating respiratory disease Download PDFInfo
- Publication number
- CN110179925A CN110179925A CN201810596577.1A CN201810596577A CN110179925A CN 110179925 A CN110179925 A CN 110179925A CN 201810596577 A CN201810596577 A CN 201810596577A CN 110179925 A CN110179925 A CN 110179925A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- cough
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 71
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 208000023504 respiratory system disease Diseases 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 19
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229940116229 borneol Drugs 0.000 claims abstract description 19
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 19
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 19
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 13
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 13
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 13
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 13
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 13
- 239000009636 Huang Qi Substances 0.000 claims abstract description 13
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 13
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 241000245665 Taraxacum Species 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- 229940079593 drug Drugs 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 4
- -1 electuary Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims 1
- 206010011224 Cough Diseases 0.000 abstract description 59
- 206010036790 Productive cough Diseases 0.000 abstract description 33
- 208000024891 symptom Diseases 0.000 abstract description 30
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract description 17
- 201000005202 lung cancer Diseases 0.000 abstract description 17
- 208000020816 lung neoplasm Diseases 0.000 abstract description 17
- 208000006673 asthma Diseases 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 12
- 208000036071 Rhinorrhea Diseases 0.000 abstract description 11
- 206010039101 Rhinorrhoea Diseases 0.000 abstract description 11
- 206010039085 Rhinitis allergic Diseases 0.000 abstract description 10
- 201000010105 allergic rhinitis Diseases 0.000 abstract description 10
- 206010006451 bronchitis Diseases 0.000 abstract description 10
- 241001465251 Ephedra sinica Species 0.000 abstract description 6
- 208000024794 sputum Diseases 0.000 abstract description 6
- 210000003802 sputum Anatomy 0.000 abstract description 6
- 239000004615 ingredient Substances 0.000 abstract description 4
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 3
- 240000001949 Taraxacum officinale Species 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 12
- 208000026435 phlegm Diseases 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 4
- 206010053779 Allergic cough Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 206010041232 sneezing Diseases 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 206010005949 Bone cancer Diseases 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 244000248021 Vitex negundo Species 0.000 description 2
- 235000013427 Vitex negundo var incisa Nutrition 0.000 description 2
- 235000014961 Vitex negundo var negundo Nutrition 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000014956 negundo chastetree Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229940044601 receptor agonist Drugs 0.000 description 2
- 239000000018 receptor agonist Substances 0.000 description 2
- 229960000278 theophylline Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- 241001412627 Adenophora liliifolia Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 241000432824 Asparagus densiflorus Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 240000005636 Dryobalanops aromatica Species 0.000 description 1
- 206010015856 Extrasystoles Diseases 0.000 description 1
- 241000605372 Fritillaria Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- GBFLZEXEOZUWRN-VKHMYHEASA-N S-carboxymethyl-L-cysteine Chemical compound OC(=O)[C@@H](N)CSCC(O)=O GBFLZEXEOZUWRN-VKHMYHEASA-N 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- JBDGDEWWOUBZPM-XYPYZODXSA-N ambroxol Chemical compound NC1=C(Br)C=C(Br)C=C1CN[C@@H]1CC[C@@H](O)CC1 JBDGDEWWOUBZPM-XYPYZODXSA-N 0.000 description 1
- 229960005174 ambroxol Drugs 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229960001040 ammonium chloride Drugs 0.000 description 1
- 230000001986 anti-endotoxic effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 229940124623 antihistamine drug Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- OJGDCBLYJGHCIH-UHFFFAOYSA-N bromhexine Chemical compound C1CCCCC1N(C)CC1=CC(Br)=CC(Br)=C1N OJGDCBLYJGHCIH-UHFFFAOYSA-N 0.000 description 1
- 229960003870 bromhexine Drugs 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 229960004399 carbocisteine Drugs 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 229940065725 leukotriene receptor antagonists for obstructive airway diseases Drugs 0.000 description 1
- 239000003199 leukotriene receptor blocking agent Substances 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention provides a kind of Chinese medicine composition and preparation method thereof for treating respiratory disease, the Chinese medicine composition includes each component of following parts by weight: 1-8 parts of Radix Glycyrrhizae, 1-4 parts of American Ginseng, 1-4 parts of honeysuckle, 0.4-3 parts of borneol, 1-5 parts of dandelion, 1-6 parts of Chinese yam, 1-6 parts of Radix Astragali, 1-4 parts of caulis bambusae in taenian.Each component generates synergistic effect in Chinese medicine composition in the present invention, with cough-relieving, resolving sputum, anti-inflammatory effect, it can significantly improve and treat the symptoms such as cough, expectoration, sneeze, runny nose as caused by the respiratory diseases such as bronchitis, obstinate asthma, lung cancer, allergic rhinitis, and the biggish ingredient Chinese ephedra of side effect is not contained in Chinese medicine composition, takes safety.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicines more particularly to a kind of Chinese medicine composition for treating respiratory disease and its preparation sides
Method.
Background technique
In recent years, as environmental pollution caused by urbanization and the acceleration of industrial process aggravates, climatic variation, life is not
Rule and the abuse factors such as cold drug and antibiotic, the disease incidence of respiratory disease show an increasing trend year by year.Cough, expectoration
It is one of clinical most commonly seen symptom and respiratory disease (such as respiratory tract infection, bronchitis, bronchial asthma, pneumonia, lung
Cancer, allergic rhinitis etc.) cardinal symptom.
For cough, expectoration symptom caused by respiratory disease, doctor trained in Western medicine mainly uses antibiotic, antiviral drugs, sugared skin at present
Matter hormone and preventing phlegm from forming and stopping coughing medicine etc., although these drugs exist in short-term, effect is obvious, and long-time service is easy to happen tolerance, stops
It coughs and is easy repeatedly after medicine, there is drug toxic side effect should not take for a long time and the drawbacks such as dependence easy to form.Compare therewith,
Chinese traditional treatment has many advantages such as treating both manifestation and root cause of disease, Small side effects.
103028001 B of Authorization Notice No. CN discloses a kind of Chinese medicine by including Chinese ephedra, radix scutellariae, Radix Glycyrrhizae and oil of negundo chastetree
Chinese medical extract made of raw material, the Chinese medicine comprising liquiritin, Chinese ephedra total alkali, baicalin and oil of negundo chastetree as active constituent mix
Object and Chinese medicine composition comprising the Chinese medical extract or Traditional Chinese drug mixture.Prescription of the invention can be used for treat and/or
Prevent inflammation in respiratory system, bronchitis, tracheitis, pneumonia etc..But in the medicine containing the biggish Chinese ephedra of side effect at
Point, and for lung cancer, the caused cough of obstinate asthma, expectoration symptom do not show effective therapeutic effect.
105641419 A of publication number CN discloses a kind of Chinese medicine composition for treating lung cancer cough due to yin deficiency, by following raw material
Medicine is made: lily, asparagus fern, radix polygonati officinalis, Radix Ophiopogonis, the root of straight ladybell, fructus lycii, mulberry, almond, rhizoma anemarrhenae, fritillaria, Radix Glycyrrhizae.The present invention can be effective
Cooperate the treatment of lung cancer and there is obvious clinical effectiveness.But the Chinese medicine composition use scope has limitation, can only be directed to
The cough caused by specific lung cancer is effective.
Current market sales of plurality of Chinese medicine is only capable of respite throat itch, cough symptom mostly, or reaches
To resolving sputum expectoration purpose, but for cough, expectoration, spray caused by bronchitis, lung cancer, obstinate asthma, allergic rhinitis
It sneezes, the symptoms such as runny nose, effect is not it is obvious that cure the period relatively long, and contains side effect in some product formulas
Biggish ingredient Chinese ephedra.
Summary of the invention
The purpose of the present invention is in view of the prior art for bronchitis, lung cancer, obstinate asthma, allergic rhinitis
The therapeutic effect of the symptoms such as caused cough, expectoration, sneeze, runny nose is less desirable, and the healing period is relatively long, some Chinese medicines
The problems such as in formula containing side effect biggish ingredient, provides the Chinese medicine composition that a kind of curative effect significantly treats respiratory disease.
It is another object of the present invention to provide a kind of preparation methods for treating respiratory disease Chinese medicine composition.
To achieve the goals above, the present invention adopts the following technical scheme:
The first aspect of the present invention provides a kind of Chinese medicine composition for treating respiratory disease, each group including following parts by weight
Point: 1-8 parts of Radix Glycyrrhizae, 1-4 parts of American Ginseng, 1-4 parts of honeysuckle, 0.4-3 parts of borneol, 1-5 parts of dandelion, 1-6 parts of Chinese yam, Radix Astragali 1-
6 parts, 1-4 parts of caulis bambusae in taenian.
Preferably, the Chinese medicine composition of the treatment respiratory disease includes each component of following parts by weight: 2-8 parts of Radix Glycyrrhizae, west
0.8-3.6 parts of American ginseng, 1.2-3.2 parts of honeysuckle, 0.4-2.2 parts of borneol, 1-3.6 parts of dandelion, 1-4 parts of Chinese yam, Radix Astragali 1.4-5
Part, 1.2-3 parts of caulis bambusae in taenian.
Preferably, the Chinese medicine composition of the treatment respiratory disease includes each component of following parts by weight: 2 parts of Radix Glycyrrhizae, the West
0.8 part, 1.2 parts of honeysuckle, 0.4 part of borneol, 1 part of dandelion, 1 part of Chinese yam, 1.4 parts of Radix Astragali, 1.2 parts of caulis bambusae in taenian of ginseng.
The second aspect of the present invention provides a kind of preparation method of Chinese medicine composition for treating respiratory disease, is used to prepare
State Chinese medicine composition, comprising the following steps:
Step 1: the medicinal raw material of weight ratio is answered to clean, sterilize by borneol foreign minister is removed in the present invention, in 60-85
It is dried 8 hours under the conditions of DEG C, then crushed 100-300 mesh and medicinal powder is made.
Step 2: the borneol of the corresponding weight ratio in the present invention is cleaned, is sterilized, then crushed 100-
Medicinal powder is made in 300 mesh.
Step 3: medicinal powder made by step 1 and step 2 is uniformly mixed.
Gained mixed powder is added and auxiliary material or auxiliary material is not added in step 3 in the preparation method, be made pulvis, spray,
Tablet, electuary, pill, capsule or granule.
The application method and dosage of Chinese medicine composition provided by the invention: pulvis is made in the Chinese medicine composition in the present invention
(every part of 3g), each taking 3g medicinal powder, taken three times per day, the early, middle and late hot taken with boiled water of half an hour after meal.
The drug action mechanism of each component of the Chinese medicine composition is as follows:
Radix Glycyrrhizae, property are sweet, flat, nontoxic.There are anti-inflammatory, antibechic, the beneficial effect of eliminating the phlegm.Control abscess of throat.
American Ginseng, property is sweet, slight bitter, trembles with fear.Can boosting qi and nourishing yin, relieve inflammation or internal heat and promote the production of body fluid.Cure mainly deficiency of vital energy yin deficiency hyperactivity of fire, cough and asthma phlegm blood, mouth
Dry dry throat.
Honeysuckle, property are sweet, warm.There is anti-inflammatory, antitoxin, resisting pathogenic microbes beneficial effect.
Borneol, also known as kapur.Property is pungent, bitter, slightly cold.All keys can be led to, dissipate stagnated fire, swelling and pain relieving.
Dandelion, property are sweet, flat.It can resisting pathogenic microbes, antiendotoxin.Cure cold fever, cough, abscess of throat etc..
Chinese yam, property are sweet, warm, flat.Kidney-nourishing gas.
Radix Astragali, property is sweet, tepor.Tonifying lung gas, lets out lung-fire.Phlegm is controlled to cough.
Caulis bambusae in taenian: property is sweet, salty, cold.Clearing heat and eliminating phlegm.
With it is existing formula compared with, it is that the present invention realizes the utility model has the advantages that
1. each component generates synergistic effect in Chinese medicine composition of the invention, treatment course is effectively shortened, can obviously be changed
It is apt to and cures cough, expectoration, sneeze, stream as caused by the respiratory diseases such as bronchitis, obstinate asthma, lung cancer, allergic rhinitis
Tears etc.；
2. and the biggish ingredient Chinese ephedra of side effect is not contained in Chinese medicine composition, and safety is taken, it is suitable for large-scale promotion
It uses.
Specific embodiment
Embodiment 1:
The Chinese medicine composition for the treatment respiratory disease that the present embodiment is enumerated, each component including following weight: Radix Glycyrrhizae 2g, the West
Join 0.8g, honeysuckle 1.2g, borneol 0.4g, dandelion 1g, Chinese yam 1g, Radix Astragali 1.4g, caulis bambusae in taenian 1.2g.
The embodiment provide Chinese medicine composition the preparation method is as follows:
Step 1: in addition to borneol, taking each component of above-mentioned weight proportion to be cleaned, sterilized, and dries under the conditions of 72.5 DEG C
It is 8 hours dry, it then crushed 200 mesh and medicinal powder be made.
Step 2: the borneol that corrresponding quality matches is cleaned, is sterilized, 200 mesh is then crushed, medicinal powder is made.
Step 3: medicinal powder made by step 1 and step 2 is uniformly mixed, and every part of 3g is packed.
Embodiment 2:
The Chinese medicine composition for the treatment respiratory disease that the present embodiment is enumerated, each component including following weight: Radix Glycyrrhizae 3.5g, west
American ginseng 1.5g, honeysuckle 1.8g, borneol 0.85g, dandelion 1.8g, Chinese yam 1.8g, Radix Astragali 2.5g, caulis bambusae in taenian 1.6g.
The preparation method is the same as that of Example 1 for the Chinese medicine composition that the embodiment provides.
Embodiment 3:
The Chinese medicine composition for the treatment respiratory disease that the present embodiment is enumerated, each component including following weight: Radix Glycyrrhizae 5g, the West
Join 2.2g, honeysuckle 2.2g, borneol 1.3g, dandelion 2.3g, Chinese yam 2.5g, Radix Astragali 3.2g, caulis bambusae in taenian 2.1g.
The preparation method is the same as that of Example 1 for the Chinese medicine composition that the embodiment provides.
Embodiment 4:
The Chinese medicine composition for the treatment respiratory disease that the present embodiment is enumerated, each component including following weight: Radix Glycyrrhizae 6.5g, west
American ginseng 3g, honeysuckle 2.5g, borneol 1.5g, dandelion 3g, Chinese yam 3.5g, Radix Astragali 4g, caulis bambusae in taenian 2.5g.
The preparation method is the same as that of Example 1 for the Chinese medicine composition that the embodiment provides.
Embodiment 5:
The Chinese medicine composition for the treatment respiratory disease that the present embodiment is enumerated, each component including following weight: Radix Glycyrrhizae 8g, the West
Join 3.6g, honeysuckle 3.2g, borneol 2.2g, dandelion 3.6g, Chinese yam 4g, Radix Astragali 5g, caulis bambusae in taenian 3g.
The preparation method is the same as that of Example 1 for the Chinese medicine composition that the embodiment provides.
With Chinese medicine composition made from embodiment 1-5 any component, investigate respiratory disease patient class statistics: (1) lung cancer is suffered from
Person 45；(2) obstinate asthma patient 38；(3) bronchitis patient 118；(4) Allergic Rhinitis 85；(5)
Allergic cough patient 80, but not limited to this five class patients.
Patients with lung cancer 45, in, after western medical treatment scheme, cough, expectoration symptom are unable to control.Through the invention Chinese medicine
After formula treatment, cough, expectoration symptom completely disappear 41, control rate 91%.
Obstinate asthma patient 38, use bronchodilator, inhaled glucocorticoids, β 2 receptor agonist, white
The drugs such as triolefin regulator, theophylline, cough are unable to control.After invention Chinese medicine preparation treatment, cough symptom completely disappears 36
Example, control rate 95%.
Chronic bronchitis patient 118, with penicillin, erythromycin, aminoglycoside, quinolones, cephalo-type etc.
Antibiotic, eliminating the phlegm, antibechic class medicine, such as mixture of ammonium chloride, bromhexine, ambroxol, carbocisteine, various Chinese patent drugs etc. are controlled
After treatment, cough, expectoration symptom are not clearly better.After invention Chinese medicine preparation treatment, cough, expectoration symptom are completely disappeared
110, cure rate 93.2%.
Allergic Rhinitis 85, after H1 antihistamine drug, Chinese herbal treatment, although sneezing, runny nose symptom have
It is controlled, but one into specific environment, sneezing, runny nose symptom can break out again, and the duration is longer, bring to patient very big
Puzzlement.After invention Chinese medicine preparation treatment, in 3-7 days, sneezing, runny nose symptom completely disappear 84, control rate
99%.
Allergic cough patient 80, use β 2 receptor agonist, theophylline, glucocorticoid, allergy preparations chlorine
Lei Tading, leukotriene receptor antagonists Meng's chlorine department spy, Chinese herbal medicine etc., can not be used for a long time, cough symptom protracted course of disease.After use
Chinese medicine preparation of the present invention, cough symptom completely disappear 78, control rate 97.5%.
Part typical case is listed below to be proved:
1. lung cancer, Bone tumour, Thyroid metastasis, male, 59 years old.Cough symptom is serious, and day and night cough, cough and asthma, lead to nothing
Method sleep, the glutinous phlegm of white, can not expectoration, sputum with blood streaks.With various traditional Chinese and western medicine drug therapies, in vain, after with the invention
Formula carries out treatment 14 days, and hemoptysis stops；Treatment 23 days, cough stop, and phlegm can be slept normal with expectoration；Hereafter 5 months, suffer from
Person is without cough, hemoptysis symptom.
2. lung cancer, Bone tumour, women, 70 years old.Cough, expectoration serious symptom, patient needs using sputum aspirator, otherwise can be because
It is excessive for phlegm, cause to suffocate.After the invention formula treatment 1 day, cough symptom is substantially reduced, does not cough substantially, sputum point
It secretes and significantly reduces, do not need using sputum aspirator.
3. lung cancer, women, 64 years old.Patient has apparent cough, expectoration symptom.After this formula 1 day, cough, expectoration disease
Shape is substantially reduced；After 7 days, cough stops, and expectoration disappears substantially.
4. lung cancer, male, 84 years old.Patient has apparent cough, expectoration symptom.After this formula 3 days, cough, expectoration disease
Shape is substantially reduced；10 days or so, cough, expectoration stopped substantially.
5. lung cancer, women, 48 years old.Patient's cough, expectoration are obvious.With in various, western medicine treatment it is all invalid, sent out with this
Bright formula treatment, after 3 days, cough, expectoration are substantially reduced；After 7 days, cough, expectoration symptom disappear substantially.
6. refractory asthma 2 years, women, 43 years old.Irritation dry cough is serious, no phlegm.With doctor trained in Western medicine asthma Normalized Treatment, relax
Benefit repeatedly, albuterol aerosol, Budinad fog preparation, Wan Tuolin etc. it is all invalid, and side reaction (cardiac response) it is obvious that
There is trigeminy.It is treated with various Chinese medicine preparations, still effect is unobvious, is formulated and is treated with the invention, and after 20 days, cough is had
Effect control, after continue to take 1 month, asthma is almost no longer broken out, so far asthma effectively control has 8 years, be completely free of west
Medicine.
7. refractory asthma, women, 52 years old.Irritation dry cough is serious, day and night coughs, and is very, to cause its nothing with nocturnal cough
Method sleep.With in various, treatment with western it is all invalid, after being treated 20 days with inventive formulation, cough symptom is completely disappeared.
8. allergic rhinitis 5 years, male, 55 years old.Sneeze, runny nose are serious.Various traditional Chinese and western medicine Regimen Chemotherapies are invalid, matched with this
Side is after 20 days, and cough, runny nose symptom completely disappear, and allergic rhinitis is effectively controlled.
9. allergic rhinitis, women, 43 years old.Sneeze, runny nose serious 2 years.Various traditional Chinese and western medicine Regimen Chemotherapies are invalid, matched with this
After 7 days, sneeze, runny nose symptom are completely disappeared for side.
10. bronchitis, German women, 35 years old.Cough, expectoration 1 year and a half are the glutinous phlegm of white in the most of the time, even
There is yellow phlegm.It is all invalid to be treated with various anti-infectives, and with the formula 3 times, cough, expectoration symptom are completely disappeared.
11. mammary cancer 1 year, women 35 years old.Cough after common cold more than 7 days, agonizing, in Shanghai, various big hospital is with various
In, western medicine it is all invalid.It takes this prescription drug 1 time, coughs substantially reduced, take 2 times, cough stops completely.
12. allergic cough, German women 40 years old is invalid with Western medicine, because cough is serious, can not work.Once take,
Cough fully controls.
13. cough infects, German women 37 years old, cough after being infected by colleague serious, after taking 1 time, cough is completely disappeared.
Chinese medicine composition of the invention can obviously improve and cure by bronchitis, obstinate asthma, lung cancer, allergia nose
The symptoms such as cough, expectoration, sneeze, runny nose caused by the respiratory diseases such as inflammation.And drug administration safety is suitble to a wide range for the treatment of to make
With.
The above specific embodiments are only exemplary, is to preferably make skilled artisans appreciate that originally
Patent, be not to be construed as include to this patent range limitation；As long as appointing made by the spirit according to disclosed in this patent
How with change or modification, the range that this patent includes is each fallen within.
Claims (6)
1. a kind of Chinese medicine composition for treating respiratory disease, which is characterized in that each component including following parts by weight: 1-8 parts of Radix Glycyrrhizae,
1-4 parts of American Ginseng, 1-4 parts of honeysuckle, 0.4-3 parts of borneol, 1-5 parts of dandelion, 1-6 parts of Chinese yam, 1-6 parts of Radix Astragali, caulis bambusae in taenian 1-4
Part.
2. Chinese medicine composition according to claim 1, which is characterized in that each component including following parts by weight: Radix Glycyrrhizae 2-8
Part, 0.8-3.6 parts of American Ginseng, 1.2-3.2 parts of honeysuckle, 0.4-2.2 parts of borneol, 1-3.6 parts of dandelion, 1-4 parts of Chinese yam, Radix Astragali
1.4-5 parts, 1.2-3 parts of caulis bambusae in taenian.
3. Chinese medicine composition according to claim 2, which is characterized in that each component including following parts by weight: Radix Glycyrrhizae 2
Part, 0.8 part of American Ginseng, 1.2 parts of honeysuckle, 0.4 part of borneol, 1 part of dandelion, 1 part of Chinese yam, 1.4 parts of Radix Astragali, 1.2 parts of caulis bambusae in taenian.
4. Chinese medicine composition according to claim 1 to 3, which is characterized in that the grain of each component in the Chinese medicine composition
Diameter is 100-300 mesh.
5. a kind of preparation method for the Chinese medicine composition for treating respiratory disease, be used to prepare claim 1-4 it is described in any item in
Drug composition, which comprises the following steps:
Step 1: the component of weight ratio is answered to clean, sterilize by borneol foreign minister is removed in claim 1, in 60-85 DEG C of condition
Lower drying 8 hours, then crushed 100-300 mesh, medicinal powder is made.
Step 2: the borneol of weight ratio corresponding in claim 1 is cleaned, is sterilized, then crushed 100-300
Medicinal powder is made in mesh.
Step 3: medicinal powder made by step 1 and step 2 is uniformly mixed.
6. the preparation method of Chinese medicine composition according to claim 5, which is characterized in that gained mixing in the step 3
Medicinal powder is added auxiliary material or auxiliary material is not added, and pulvis, spray, tablet, electuary, pill, capsule or granule is made.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810596577.1A CN110179925A (en) | 2018-06-11 | 2018-06-11 | A kind of Chinese medicine composition and preparation method thereof for treating respiratory disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810596577.1A CN110179925A (en) | 2018-06-11 | 2018-06-11 | A kind of Chinese medicine composition and preparation method thereof for treating respiratory disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110179925A true CN110179925A (en) | 2019-08-30 |
Family
ID=67713619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810596577.1A Pending CN110179925A (en) | 2018-06-11 | 2018-06-11 | A kind of Chinese medicine composition and preparation method thereof for treating respiratory disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110179925A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116439334A (en) * | 2023-03-24 | 2023-07-18 | 云南贝泰妮生物科技集团股份有限公司 | Plant concentrated drink for improving respiratory tract immunity and preparation process thereof |
| CN116616395A (en) * | 2023-03-24 | 2023-08-22 | 云南贝泰妮生物科技集团股份有限公司 | Plant solid beverage for improving respiratory tract immunity and preparation process thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102205044A (en) * | 2011-05-13 | 2011-10-05 | 范圣刚 | Medicament for treating cough |
| CN103239517A (en) * | 2012-02-08 | 2013-08-14 | 郭进军 | Traditional Chinese medicine composition resistant to NDM-1 medicine resistant gene bacteria (superbacteria) |
-
2018
- 2018-06-11 CN CN201810596577.1A patent/CN110179925A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102205044A (en) * | 2011-05-13 | 2011-10-05 | 范圣刚 | Medicament for treating cough |
| CN103239517A (en) * | 2012-02-08 | 2013-08-14 | 郭进军 | Traditional Chinese medicine composition resistant to NDM-1 medicine resistant gene bacteria (superbacteria) |
Non-Patent Citations (1)
| Title |
|---|
| 朱宝珍 等: "射干抗病毒注射液治疗上呼吸道感染疗效观察", 《中医社区医师》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116439334A (en) * | 2023-03-24 | 2023-07-18 | 云南贝泰妮生物科技集团股份有限公司 | Plant concentrated drink for improving respiratory tract immunity and preparation process thereof |
| CN116616395A (en) * | 2023-03-24 | 2023-08-22 | 云南贝泰妮生物科技集团股份有限公司 | Plant solid beverage for improving respiratory tract immunity and preparation process thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102145114B (en) | Novel traditional Chinese medicine for treating cold | |
| CN104352587A (en) | Ointment for treating rhinitis | |
| CN102091191B (en) | Medicament for treating chronic pharyngitis | |
| CN102475863A (en) | Chinese medicine for treating chronic bronchitis | |
| CN110179925A (en) | A kind of Chinese medicine composition and preparation method thereof for treating respiratory disease | |
| CN102688384B (en) | Traditional Chinese medicine decoction for treating chronic pharyngitis | |
| CN114632129B (en) | Traditional Chinese medicine for treating pediatric cough variant asthma and preparation method thereof | |
| CN102935149B (en) | A kind of composition and method of making the same for the treatment of domestic animal respiratory tract disease | |
| CN104491825B (en) | A kind of Chinese medicine ointment for the treatment of oral ulcer | |
| CN103990061A (en) | Traditional Chinese medicine composition for treating cough with lung heat | |
| CN105879000A (en) | Pharmaceutic preparation for treating tonsillitis and application thereof | |
| CN101129543A (en) | Chinese ephedra Huagai powder | |
| CN105796746B (en) | Traditional Chinese medicine for preventing and treating recurrent upper respiratory tract infection | |
| CN105106601A (en) | Medicinal preparation for treating acute nasopharyngitis | |
| CN111407808A (en) | Epidemic-resistant traditional Chinese medicine composition, preparation method and pharmaceutical application thereof | |
| CN111184823A (en) | A fumigation bath preparation for preventing and treating pestilence, and its application method and application | |
| CN116585370B (en) | Traditional Chinese medicine composition and application thereof in preparation of medicine for treating/preventing acute upper respiratory tract infection | |
| CN103223075B (en) | Traditional Chinese medicinal capsule for treating diphtheria | |
| CN101693058B (en) | Medicament for preventing and treating cold and inflammation infection | |
| CN105412494A (en) | Medicine for treating cold | |
| CN105343485A (en) | Medicine composition for treating nasosinusitis and application thereof | |
| CN111773364A (en) | Traditional Chinese medicine preparation for treating asthma | |
| CN102716290B (en) | Traditional Chinese medicine for treating bronchial asthma | |
| CN104474270A (en) | Traditional Chinese medicine composition and application thereof | |
| CN117205257A (en) | Traditional Chinese medicine composition with cough relieving and phlegm reducing effects |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190830 |